Mertens J - Search Results

1

Oral R115866 in the treatment of moderate to severe plaque-type psoriasis.

Verfaille CJ, Thissen CA, Bovenschen HJ, Mertens J, Steijlen PM, van de Kerkhof PC. Verfaille CJ, et al. Among authors: mertens j. J Eur Acad Dermatol Venereol. 2007 Sep;21(8):1038-46. doi: 10.1111/j.1468-3083.2007.02158.x. J Eur Acad Dermatol Venereol. 2007. PMID: 17714122 Clinical Trial.

2

Oral R115866 in the treatment of moderate to severe facial acne vulgaris: an exploratory study.

Verfaille CJ, Coel M, Boersma IH, Mertens J, Borgers M, Roseeuw D. Verfaille CJ, et al. Among authors: mertens j. Br J Dermatol. 2007 Jul;157(1):122-6. doi: 10.1111/j.1365-2133.2007.07896.x. Epub 2007 Apr 25. Br J Dermatol. 2007. PMID: 17459036

3

Disease recurrence in localized scleroderma: a retrospective analysis of 344 patients with paediatric- or adult-onset disease.

Mertens JS, Seyger MM, Kievit W, Hoppenreijs EP, Jansen TL, van de Kerkhof PC, Radstake TR, de Jong EM. Mertens JS, et al. Br J Dermatol. 2015 Mar;172(3):722-8. doi: 10.1111/bjd.13514. Epub 2015 Feb 8. Br J Dermatol. 2015. PMID: 25381928

4

Beliefs About Medicines in Patients with Psoriasis Treated with Methotrexate or Biologics: A Cross-sectional Survey Study.

Otero ME, van den Reek JMPA, van de Kerkhof PCM, Mertens JS, Seyger MMB, Kievit W, de Jong EMGJ. Otero ME, et al. Among authors: mertens js. Acta Derm Venereol. 2019 Apr 1;99(4):386-392. doi: 10.2340/00015555-3108. Acta Derm Venereol. 2019. PMID: 30543381 Free article.

5

Use of Mycophenolate Mofetil in Patients with Severe Localized Scleroderma Resistant or Intolerant to Methotrexate.

Mertens JS, Marsman D, van de Kerkhof PC, Hoppenreijs EP, Knaapen HK, Radstake TR, de Jong EM, Seyger MM. Mertens JS, et al. Acta Derm Venereol. 2016 May;96(4):510-3. doi: 10.2340/00015555-2297. Acta Derm Venereol. 2016. PMID: 26582717 Free article.

6

Drug Survival and Predictors of Drug Survival for Methotrexate Treatment in a Retrospective Cohort of Adult Patients with Localized Scleroderma.

Mertens JS, van den Reek JM, Kievit W, van de Kerkhof PC, Thurlings RM, Radstake TR, Seyger MM, de Jong EM. Mertens JS, et al. Acta Derm Venereol. 2016 Nov 2;96(7):943-947. doi: 10.2340/00015555-2411. Acta Derm Venereol. 2016. PMID: 26983450 Free article.

7

Morphea and Eosinophilic Fasciitis: An Update.

Mertens JS, Seyger MMB, Thurlings RM, Radstake TRDJ, de Jong EMGJ. Mertens JS, et al. Am J Clin Dermatol. 2017 Aug;18(4):491-512. doi: 10.1007/s40257-017-0269-x. Am J Clin Dermatol. 2017. PMID: 28303481 Free PMC article. Review.

8

High-Dose Intravenous Pulse Methotrexate in Patients With Eosinophilic Fasciitis.

Mertens JS, Zweers MC, Kievit W, Knaapen HK, Gerritsen M, Radstake TR, van den Hoogen FH, Creemers MC, de Jong EM. Mertens JS, et al. JAMA Dermatol. 2016 Nov 1;152(11):1262-1265. doi: 10.1001/jamadermatol.2016.2873. JAMA Dermatol. 2016. PMID: 27541801 Clinical Trial.

9

Long-term outcome of eosinophilic fasciitis: A cross-sectional evaluation of 35 patients.

Mertens JS, Thurlings RM, Kievit W, Seyger MMB, Radstake TRD, de Jong EMGJ. Mertens JS, et al. J Am Acad Dermatol. 2017 Sep;77(3):512-517.e5. doi: 10.1016/j.jaad.2017.05.018. Epub 2017 Jul 19. J Am Acad Dermatol. 2017. PMID: 28734566

10

The identification of CCL18 as biomarker of disease activity in localized scleroderma.

Mertens JS, de Jong EMGJ, van den Hoogen LL, Wienke J, Thurlings RM, Seyger MMB, Hoppenreijs EPAH, Wijngaarde CA, van Vlijmen-Willems IMJJ, van den Bogaard E, Giovannone B, van Wijk F, van Royen-Kerkhof A, Marut W, Radstake TRD. Mertens JS, et al. J Autoimmun. 2019 Jul;101:86-93. doi: 10.1016/j.jaut.2019.04.008. Epub 2019 Apr 18. J Autoimmun. 2019. PMID: 31006523

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

567 results

Search Page